Trading

Data

Solutions

Insights

HeartFlow Stock

heartflow.comHealthcareFounded: 2007Funding to Date: $528.88MM

HeartFlow is revolutionizing precision heart care, combining human ingenuity with advanced AI technology. The founders began their journey to improve coronary artery disease diagnosis and HeartFLow has now now expanded its product portfolio to include anatomic stenosis and plaque information. This company was founded by Charles Taylor, Christopher Zarins, and John Stevens in 2007 and is headquartered in Redwood City, CA.

Buy or sell HeartFlow stock Learn more about HeartFlow IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for HeartFlow.

Register Today

HeartFlow investors also invested in these private companies

Wellington Management

Scale AI, Dataminr, Patreon, Airbnb, Arcadia, Lookout, Synthego, Prove, FalconX, SeatGeek

US Venture Partners

Postman, H2O.ai, Observe.AI, Apollo, HeartFlow, PubMatic, ShopClues, Snapdeal

Capricorn Investment Group

Helion Energy, Redwood Materials, HeartFlow, Joby Aviation, Porch, Innovium

Sweetwater Private Equity

ThoughtSpot, Savage X Fenty, AliveCor, Blink Health, HeartFlow

Spur Capital Partners

Anduril, Netskope, Rubrik, Outreach, Calm, Flock Safety, HeartFlow, Cybereason, Oyo

Team

Management Team

Campbell Rogers MD

Chief Medical Officer & Executive Vice President

Charles Taylor Ph.D

Co-Founder, Chief Scientific Officer & Board Member

Noemi Espinosa JD

Chief Ethics & Compliance Officer & General Counsel

Christopher Zarins MD

Co-Founder, Senior Advisor on Clinical Science & Senior Vice President of Medical Affairs

John Farquhar

Chief Executive Officer, President & Board Member

Monica Tellado

Chief Financial Officer

Board Members

William Weldon

Board Member

Jeffrey Lightcap

HealthCor Partners Management

Lonnie Smith

Board Member

Casey Tansey

US Venture Partners

Barry Uphoff

Capricorn Investment Group

Other companies like HeartFlow in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Altos Labs

Sector

Healthcare

Last Round Est. Valuation

$3.67B

Headspace

Sector

Healthcare

Last Round Est. Valuation

$298.33MM

Mammoth Biosciences

Sector

Healthcare

Last Round Est. Valuation

$1.08B

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

NowRx

Sector

Healthcare

Last Round Est. Valuation

$334.19MM

Theracos

Sector

Healthcare

Last Round Est. Valuation

$327.39MM

Sector

Sector

Last Round Est. Valuation

$500MM

News

Forbes 02/04/2019

Top Five Digital Health Technologies in 2019

For 2019, we asked companies around the world one basic question: “Please indicate the key technology which you believe will have the most profound impact on the healthcare industry during 2019?” The results are not very surprising:

Forbes 08/29/2018

Why HeartFlow’s Data From This Weekend Don’t Change Anything

The $1.5 billion health-tech startup HeartFlow has a noninvasive test for heart disease based on machine learning analysis of CT scans. Two new studies are unlikely to win over its critics.

Forbes 08/27/2018

HeartFlow Has Raised $500 Million For A Test To Detect Heart Disease. Does It Make Patients Better Off?

The valuation is based on a big idea: a noninvasive test that peers into a patient’s coronary arteries to see how blocked they are.

Popular Topics

Popular Topics

HeartFlow Stock

Register for Details